Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018)
Arcturus Therapeutics Holdings' (ARCT) quarterly Treasury Shares came in at $18786.0 in Q4 2025, little changed YoY from $18786.0 in Q4 2024, and little changed on a QoQ basis from $18786.0 in Q4 2024.
Analysis
Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018) Analysis & Trends
Arcturus Therapeutics Holdings (ARCT) has 4 years of Treasury Shares data on file, last reported at $18786.0 in Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $18786.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18786.0 (changed 0.0% YoY) and the FY2025 annual result came in at $18786.0, changed 0.0% from the prior year.
- Treasury Shares held at $18786.0 in Q4 2025, from $18786.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $18786.0 in Q4 2023 to a low of $18786.0 in Q4 2023.
- A 3-year average of $18786.0 and a median of $18786.0 in 2023 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 0.0% in 2024, down 0.0% in 2024.
- Tracing ARCT's Treasury Shares over 3 years: stood at $18786.0 in 2023, then changed by 0.0% to $18786.0 in 2024, then changed by 0.0% to $18786.0 in 2025.
- The last three Treasury Shares figures came in at $18786.0 (Q4 2025), $18786.0 (Q4 2024), and $18786.0 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Arcturus Therapeutics Holdings | 449.65 Mn | 258.17 Mn | - | - |